Scarica l'app Stockscreener
6.25
1.46%
0.09
Dopo l'orario di chiusura:
6.25
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
(EPRX.WT.A) Strategic Equity Report - news.stocktradersdaily.com
How to Take Advantage of moves in (EPRX) (EPRX:CA) - news.stocktradersdaily.com
FY2025 Earnings Estimate for EPRX Issued By Lifesci Capital - Defense World
(EPRX.WT.A) Risk-Controlled Trading Report - news.stocktradersdaily.com
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 0.3% – Here’s Why - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Raised to Strong-Buy at Lifesci Capital - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Rating Upgraded by Wall Street Zen - Defense World
New Highs: How Eupraxia Pharmaceuticals Inc stock reacts to global recession fears2025 Historical Comparison & Fast Moving Trade Plans - moha.gov.vn
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat
Eupraxia Pharmaceuticals Inc. (EPRXF) Competitors - Meyka
(EPRX.WT.A) Investment Analysis and Advice - news.stocktradersdaily.com
(EPRX) Technical Pivots with Risk Controls (EPRX:CA) - news.stocktradersdaily.com
Analysts see more than 77% upside for Eupraxia Pharmaceuticals (EPRX), here’s why - MSN
CapEx per share of Eupraxia Pharmaceuticals Inc Warrant 2021-09.03.2026 on Eupraxia Pharma Rg – TSX:EPRX.WT - TradingView
Is Eupraxia Pharmaceuticals Inc. stock oversold or undervaluedWeekly Trade Review & Verified Technical Signals - Newser
Will Eupraxia Pharmaceuticals Inc. (X43) stock outperform global peersJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why - Finviz
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here’s Why - Yahoo Finance
(EPRX.WT.A) Comprehensive Trading Strategy Report - news.stocktradersdaily.com
Return on invested capital % of Eupraxia Pharmaceuticals, Inc. – LS:A3EGRS - TradingView — Track All Markets
Net current asset value per share of Eupraxia Pharmaceuticals, Inc. – LS:A3EGRS - TradingView
Is Eupraxia Pharmaceuticals Inc. stock a bargain at current levelsWeekly Trade Review & Long-Term Safe Investment Plans - Newser
Is Eupraxia Pharmaceuticals Inc. (X43) stock testing key supportJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
How Eupraxia Pharmaceuticals Inc. (X43) stock correlates with oil markets2025 Institutional Moves & Weekly High Potential Alerts - Newser
How forex fluctuations impact Eupraxia Pharmaceuticals Inc. (X43) stockPortfolio Performance Report & Stock Market Timing Techniques - Newser
Is Eupraxia Pharmaceuticals Inc. (X43) stock expanding market penetration2025 Key Lessons & Low Risk High Win Rate Picks - Newser
(EPRX) Investment Analysis and Advice (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. (EPRX.TO) stock price, news, quote and history - Yahoo Finance UK
Eupraxia Pharmaceuticals (EPRX) Stock Analysis Report | Financials & Insights - Benzinga
How Eupraxia Pharmaceuticals Inc. (X43) stock behaves under inflation pressureOptions Play & Daily Profit Focused Stock Screening - Newser
(EPRX.WT.A) Stock Market Analysis - news.stocktradersdaily.com
Scotia Capital Inc. Reduces Stake in Eupraxia Pharmaceuticals Inc. $EPRX - MarketBeat
(EPRX.WT.A) On The My Stocks Page - news.stocktradersdaily.com
Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidanceChart Signals & Expert Approved Momentum Trade Ideas - moha.gov.vn
Paul Brennan Bought 60% More Shares In Eupraxia Pharmaceuticals - simplywall.st
Eupraxia Pharmaceuticals Appoints New CFO Amid Leadership Transition - MSN
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolutionTrade Analysis Report & AI Based Buy/Sell Signal Reports - moha.gov.vn
Eupraxia Pharmaceuticals Inc. $EPRX Shares Sold by TD Waterhouse Canada Inc. - MarketBeat
Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targetsMarket Sentiment Summary & Long-Term Growth Stock Strategies - BỘ NỘI VỤ
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
(EPRX) Investment Analysis (EPRX:CA) - news.stocktradersdaily.com
(EPRX.WT.A) Long Term Investment Analysis - news.stocktradersdaily.com
Wall Street Zen Downgrades Eupraxia Pharmaceuticals (NASDAQ:EPRX) to Sell - MarketBeat
(EPRX) Investment Report (EPRX:CA) - news.stocktradersdaily.com
Why Eupraxia Pharmaceuticals Inc. stock is favored by top institutionsWeekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Bank of Montreal Can Has $215,000 Holdings in Eupraxia Pharmaceuticals Inc. $EPRX - Defense World
Is Eupraxia Pharmaceuticals Inc. (X43) stock supported by strong fundamentals2025 Market Overview & Real-Time Volume Analysis - newser.com
Eupraxia Pharmaceuticals Inc. stock trend forecastTrade Ideas & Fast Moving Market Watchlists - newser.com
How Eupraxia Pharmaceuticals Inc. (X43) stock compares with top peersMarket Rally & Risk Managed Investment Strategies - newser.com
0.39%
1.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):